CIPARS248, 249 Canada AMR Publicly Infection/ Hospital and Includes Selected Website; surveillance funded organism community susceptibility bacterial quarterly and (PHAC) testing of organisms summaries antimicrobial human clinical (E. coli and annual consumption isolates 0157:H7, reports; Salmonella DDD/1000 spp., patient spp.) isolated from human, animal and food sources CNISP248, 249 Canada (54 HAI Publicly Infection/ Hospital Rates Nosocomial Website; sentinel (since surveillance funded organism pathogens regional and hospitals in 1994) (PHAC) and trends of (MRSA, VRE, national 10 HAI ESBL web-based provinces) C. difficile, data entry resistant Canadian Network of AMR Publicly Organism Hospital/ Susceptibility Streptococcus Website; National Centre Canadian surveillance funded community testing of and annual for reference (PHAC) Streptococcus Enterococcus reports; laboratories and Enterococcus publications isolates
CIPARS248, 249 Canada AMR surveillance and antimicrobial consumption Publicly funded (PHAC) Infection/ organism Hospital and community Includes susceptibility testing of human clinical isolates Selected bacterial organisms (E. coli 0157:H7, Salmonella spp., spp.) isolated from human, animal and food sources Website; quarterly summaries and annual reports; DDD/1000 patient CNISP248, 249 Canada (54 sentinel hospitals in 10 provinces) (since 1994) HAI surveillance Publicly funded (PHAC) Infection/ organism Hospital Rates and trends of HAI Nosocomial pathogens (MRSA, VRE, ESBL C. difficile, resistant Website; regional and national web-based data entry Canadian National Centre for Network of Canadian reference laboratories AMR surveillance Publicly funded (PHAC) Organism Hospital/ community Susceptibility testing of Streptococcus and Enterococcus isolates Streptococcus and Enterococcus Website; annual reports; publications
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx